-
Patent protection to be received for L-Max® in the USA
-
Further endorsement that L-Max® is novel, inventive, industry applicable and patentable
-
PCT International Patent Applications for L-Max® in other key jurisdiction remain in progress
Lepidico Ltd (ASX:LPD) (“Lepidico” or “Company”) is pleased to announce that its L-Max® process technology, the subject of International Patent Application PCT/AU2015/000608, has achieved another milestone with the United States Patent and Trademark Office advising it has issued a Notice of Allowance. The Notice of Allowance shows the patent application is complete and meets all requirements. It is the final step in the long and complex patent process in the US. The L-Max® patent application (No 15/514.688) has been fully examined and is allowed for issuance as a patent within the United States of America. All that remains is for Lepidico to pay the remaining fees within three months, which it has now been advised is done, and the US patent will issue in about one month. National and regional phase patent applications are well advanced in other key jurisdictions.
For further information please download the attached PDF:
Download this document
